124 related articles for article (PubMed ID: 9819886)
1. [Effectiveness of moclobemide in therapy-resistant depression].
Andriushchenko AV; Kolesnikov DB
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):34-7. PubMed ID: 9819886
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
König F; Wolfersdorf M
Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
[TBL] [Abstract][Full Text] [Related]
3. Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
König F; Wolfersdorf M; Löble M; Wössner S; Hauger B
Pharmacopsychiatry; 1997 Jul; 30(4):125-7. PubMed ID: 9271778
[TBL] [Abstract][Full Text] [Related]
4. Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression.
Tanghe A; Geerts S; Van Dorpe J; Brichard B; Bruhwyler J; Géczy J
Acta Psychiatr Scand; 1997 Aug; 96(2):134-41. PubMed ID: 9272198
[TBL] [Abstract][Full Text] [Related]
5. [Aurorix--an antidepressant with a wide spectrum of action].
Iakovlev VA
Voen Med Zh; 1998 Apr; 319(4):50-2. PubMed ID: 9633256
[No Abstract] [Full Text] [Related]
6. Moclobemide for depression.
Drug Ther Bull; 1994 Jan; 32(1):6-8. PubMed ID: 7635005
[TBL] [Abstract][Full Text] [Related]
7. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
8. [Moclobemide].
Gleiter C; Volz HP
Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1175-6. PubMed ID: 7656852
[No Abstract] [Full Text] [Related]
9. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
Lotufo-Neto F; Trivedi M; Thase ME
Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483
[TBL] [Abstract][Full Text] [Related]
10. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
Volz HP; Gleiter CH; Möller HJ
Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
[TBL] [Abstract][Full Text] [Related]
11. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
[TBL] [Abstract][Full Text] [Related]
12. [A new generation of antidepressive agents -- monoamine oxidase inhibitors].
Dubnitskaia EB
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):63-8. PubMed ID: 9819893
[No Abstract] [Full Text] [Related]
13. Acute therapy of depression.
Bech P
J Clin Psychiatry; 1993 Aug; 54 Suppl():18-27; discussion 28. PubMed ID: 8253702
[TBL] [Abstract][Full Text] [Related]
14. Moclobemide and the reversible inhibitors of monoamine oxidase antidepressants.
Priest RG
Acta Psychiatr Scand Suppl; 1990; 360():39-41. PubMed ID: 2248065
[No Abstract] [Full Text] [Related]
15. RIMA: a safe concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
Delini-Stula A; Mikkelsen H; Angst J
J Affect Disord; 1995 Oct; 35(1-2):21-30. PubMed ID: 8557884
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with selective and reversible monoamine oxidase inhibitors in depressed patients: is there a biological effect proportional to the dose?].
Radat F; Berlin I; Varoquaux O; Ferreri M; Puech A
Ann Med Psychol (Paris); 1996 Jun; 154(3):204-6. PubMed ID: 8766502
[No Abstract] [Full Text] [Related]
18. Social phobia: long-term treatment outcome and prediction of response--a moclobemide study.
Versiani M; Amrein R; Montgomery SA
Int Clin Psychopharmacol; 1997 Sep; 12(5):239-54. PubMed ID: 9466158
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
Roth M; Guelfi JD
Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
[TBL] [Abstract][Full Text] [Related]
20. Studies of reversible and selective inhibitors of monoamine oxidase A in dysthymia.
Pétursson H
Acta Psychiatr Scand Suppl; 1995; 386():36-9. PubMed ID: 7717093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
